Dugi KA - Search Results

1

Low hepatic lipase activity is a novel risk factor for coronary artery disease.

Dugi KA, Brandauer K, Schmidt N, Nau B, Schneider JG, Mentz S, Keiper T, Schaefer JR, Meissner C, Kather H, Bahner ML, Fiehn W, Kreuzer J. Dugi KA, et al. Circulation. 2001 Dec 18;104(25):3057-62. doi: 10.1161/hc5001.100795. Circulation. 2001. PMID: 11748100

2

Activity and concentration of lipoprotein lipase in post-heparin plasma and the extent of coronary artery disease.

Dugi KA, Schmidt N, Brandauer K, Ramacher D, Fiehn W, Kreuzer J. Dugi KA, et al. Atherosclerosis. 2002 Jul;163(1):127-34. doi: 10.1016/s0021-9150(01)00752-3. Atherosclerosis. 2002. PMID: 12048130

3

The proline 12 alanine substitution in the peroxisome proliferator--activated receptor-gamma2 gene is associated with lower lipoprotein lipase activity in vivo.

Schneider J, Kreuzer J, Hamann A, Nawroth PP, Dugi KA. Schneider J, et al. Among authors: dugi ka. Diabetes. 2002 Mar;51(3):867-70. doi: 10.2337/diabetes.51.3.867. Diabetes. 2002. PMID: 11872694

4

Siblings with hepatosplenomegaly and lipoprotein lipase deficiency.

Schneider JG, Schaefer S, Lettgen B, Keiper T, Nawroth PP, Dugi KA. Schneider JG, et al. Among authors: dugi ka. Lancet. 2002 Oct 12;360(9340):1150. doi: 10.1016/S0140-6736(02)11202-5. Lancet. 2002. PMID: 12387965 No abstract available.

5

Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo.

Schneider JG, von Eynatten M, Schiekofer S, Nawroth PP, Dugi KA. Schneider JG, et al. Among authors: dugi ka. Diabetes Care. 2005 Sep;28(9):2181-6. doi: 10.2337/diacare.28.9.2181. Diabetes Care. 2005. PMID: 16123487

6

Novel site in lipoprotein lipase (LPL415;-438) essential for substrate interaction and dimer stability.

Keiper T, Schneider JG, Dugi KA. Keiper T, et al. Among authors: dugi ka. J Lipid Res. 2001 Aug;42(8):1180-6. J Lipid Res. 2001. PMID: 11483618 Free article.

7

Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance.

von Eynatten M, Schneider JG, Humpert PM, Rudofsky G, Schmidt N, Barosch P, Hamann A, Morcos M, Kreuzer J, Bierhaus A, Nawroth PP, Dugi KA. von Eynatten M, et al. Among authors: dugi ka. Diabetes Care. 2004 Dec;27(12):2925-9. doi: 10.2337/diacare.27.12.2925. Diabetes Care. 2004. PMID: 15562208

8

Atorvastatin improves diabetic dyslipidemia and increases lipoprotein lipase activity in vivo.

Schneider JG, von Eynatten M, Parhofer KG, Volkmer JE, Schiekofer S, Hamann A, Nawroth PP, Dugi KA. Schneider JG, et al. Among authors: dugi ka. Atherosclerosis. 2004 Aug;175(2):325-31. doi: 10.1016/j.atherosclerosis.2004.04.003. Atherosclerosis. 2004. PMID: 15262189 Clinical Trial.

9

Association between a gene variant near ataxia telangiectasia mutated and coronary artery disease in men.

Schiekofer S, Bobak I, Kleber ME, Maerz W, Rudofsky G, Dugi KA, Schneider JG. Schiekofer S, et al. Among authors: dugi ka. Diab Vasc Dis Res. 2014 Jan;11(1):60-3. doi: 10.1177/1479164113514232. Epub 2013 Nov 26. Diab Vasc Dis Res. 2014. PMID: 24281401 Free article.

10

Serum adiponectin levels are an independent predictor of the extent of coronary artery disease in men.

von Eynatten M, Schneider JG, Humpert PM, Kreuzer J, Kuecherer H, Katus HA, Nawroth PP, Dugi KA. von Eynatten M, et al. Among authors: dugi ka. J Am Coll Cardiol. 2006 May 16;47(10):2124-6. doi: 10.1016/j.jacc.2006.02.033. Epub 2006 Apr 24. J Am Coll Cardiol. 2006. PMID: 16697337 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters